Literature DB >> 1641107

Improved cerebral blood flow and CO2 reactivity after microvascular anastomosis in patients at high risk for recurrent stroke.

D E Anderson1, M P McLane, O H Reichman, T C Origitano.   

Abstract

The medical community has not yet identified cerebrovascular pathophysiological factors that distinguish patients at high risk for stroke or aid in selecting patients for microvascular cerebral bypass. In this study, we describe the courses of 13 patients, all of whom suffered recurrent episodes of transient cerebral ischemia after previous cerebral infarction. These patients underwent regional cerebral blood flow studies using xenon inhalation with a CO2 challenge before and at various times after extracerebral-to-intracerebral microvascular anastomosis. Collateral circulation was assessed in all patients before surgery using four-vessel cerebral angiography. Patients were followed for a mean of 30 months (range, 1-7 yr) after the anastomosis. Measurements of mean cortical cerebral blood flow, as measured using the initial Slope Index, and CO2 cerebrovascular reactivity of these 13 patients were compared with those in a group of 20 patients designed as controls. Hemispheric cortical blood flow was significantly depressed in these patients before surgery compared with those in the control group (P less than 0.05). After the bypass, the mean resting Initial Slope Index in these patients increased 14% (P = 0.0005). Cerebral blood flow both before and after CO2 inhalation improved significantly in these patients after surgery (P = 0.001). Detectors bordering computed tomographic or magnetic resonance image documented infarctions, identified as peri-infarct regions, and demonstrated significant mean increases in both cerebral blood flow (38.8-43.2 ml/min/100 g, P = 0.05) and CO2 cerebrovascular reactivity in these patients after bypass (1.71 + 1.91% to 4.00 + 2.38% change Initial Slope Index/mm Hg CO2, P = 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1641107     DOI: 10.1227/00006123-199207000-00005

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  Long term evaluation of brain perfusion with magnetic resonance in high flow extracranial-intracranial saphenous graft bypass.

Authors:  Alessandro Bozzao; Fabrizio Fasoli; Vanina Finocchi; Giuseppe Santoro; Andrea Romano; Luigi Maria Fantozzi
Journal:  Eur Radiol       Date:  2006-05-30       Impact factor: 5.315

2.  Extracranial-intracranial bypass in cerebral ischemia.

Authors:  Roger D Smith
Journal:  Ochsner J       Date:  2003

3.  Middle cerebral artery stenosis: endovascular and surgical options.

Authors:  Jeffrey D Klopfenstein; Francisco A Ponce; Louis J Kim; Felipe C Albuquerque; Peter Nakaji; Robert F Spetzler
Journal:  Skull Base       Date:  2005-08

4.  Long-term evaluation of EC-IC bypass patency.

Authors:  U Schick; M Zimmermann; D Stolke
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  Cerebral haemodynamics and long-term prognosis after extracranial-intracranial bypass surgery.

Authors:  T Ishikawa; K Houkin; H Abe; M Isobe; H Kamiyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

6.  Role of impaired CO2 reactivity in the diagnosis of cerebral low flow infarcts.

Authors:  R W Baumgartner; M Regard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

7.  Cortical blood flow and cognition after extracranial-intracranial bypass in a patient with severe carotid occlusive lesions. A three-year follow-up study.

Authors:  Y Tsuda; K Yamada; T Hayakawa; Y Ayada; S Kawasaki; H Matsuo
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

8.  Assessment of cerebrovascular reserve before and after STA-MCA bypass surgery by SPECT and SPM analysis.

Authors:  Joo-Hyun O; Kyung-Sool Jang; Ie-Ryung Yoo; Sung-Hoon Kim; Soo-Kyo Chung; Hyung Sun Sohn; Hyung-Kyun Rha; Hae-Kwan Park; Yong-An Chung; Jaeseung Jeong
Journal:  Korean J Radiol       Date:  2007 Nov-Dec       Impact factor: 3.500

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.